Patienter i behandling med coumarin antikoagulanter skal derfor monitoreres tæt ved begyndelsen og slutningen af glucosamin- behandling.
Patients treated with coumarin anticoagulants should therefore be monitored closely when initiating or ending glucosamine therapy.